Pre-surgical statin-treatment in a window-of-opportunity breast cancer trial: Changes in gene expression profiles

被引：0
|
作者：
Bjarnadottir, Olof [1 ]
Johansson, Ida [1 ]
Veerla, Srinivas [2 ]
Jirstrom, Karin [3 ]
Grabau, Dorthe [3 ]
Hedenfalk, Ingrid [1 ]
Borgquist, Signe [1 ]
机构：
[1] Lund Univ, Div Oncol, Dept Clin Sci, Lund, Sweden
[2] Lund Univ, SCIBLU Genom, Lund, Sweden
[3] Lund Univ, Div Pathol, Lund, Sweden
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-CT308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT308
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant tamoxifen therapy reactivates tumor suppressor protein p53 in luminal breast cancer patients: Results from a window-of-opportunity clinical trial
    Das, Gokul M.
    Kulkarni, Swati A.
    Oturkar, Chetan
    Rosario, Spencer
    Edge, Stephen B.
    Wang, Jianmin
    Swetzig, Wendy M.
    Hutson, Alan D.
    Kaipparettu, Benny
    Groman, Adrienne
    Adjei, Araba
    Goey, Andrew K.
    Morrison, Carl D.
    Kumar, Shicha
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [42] A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer (vol 22, 4, 2020)
    Goldstein, Lori J.
    Perez, Raymond P.
    Yardley, Denise
    Han, Linda K.
    Reuben, James M.
    Gao, Hui
    McCanna, Susan
    Butler, Beth
    Ruffini, Pier Adelchi
    Liu, Yi
    Rosato, Roberto R.
    Chang, Jenny C.
    [J]. BREAST CANCER RESEARCH, 2020, 22 (01)
  • [43] Clinical outcomes and exploratory gene expression analysis of OPPORTUNE: a phase II window-of-opportunity study to evaluate pictilisib plus anastrozole versus anastrozole alone in ER-positive breast cancer
    Chibly, Alejandro Martinez
    Shia, Alice
    Johnson, Radia
    Hwang, Michael S.
    Hafner, Marc
    Metcalfe, Ciara
    Shah, Kalpit
    Slyper, Michal
    Bolen, Chris
    Pinder, Sarah E.
    Thompson, Alastair M.
    Gendreau, Steven
    Schmid, Peter
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [44] SERENA-3: A randomized pre-surgical window of opportunity study assessing dose and duration of camizestrant treatment in post-menopausal women with ER-positive, HER2-negative primary breast cancer
    Robertson, John
    Gogitidze, Teimuraz
    Katashvili, Zaza
    Rocha, Juan Enrique Bargallo
    Arkania, Ekaterine
    Moppett, Iain
    Cheung, Kwok-Leung
    Nemsadze, Gia
    Ajimi, Maxine
    Irurzun-Arana, Itziar
    Lindemann, Justin
    Klinowska, Teresa
    Mathewson, Alastair
    Morrow, Christopher
    Nikolaou, Myria
    Dzagnidze, Giorgi
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [45] Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial
    John Castle
    Emma Blower
    Nigel J. Bundred
    James R. Harvey
    Jecko Thachil
    Andrea Marshall
    Karina Cox
    Silvia Cicconi
    Chris Holcombe
    Carlos Palmieri
    Cliona C. Kirwan
    [J]. Trials, 21
  • [46] A Randomized, Double-Blind, Placebo-Controlled Window-of-Opportunity Trial Evaluating Clinical Effects of High-Dose Vitamin D in Patients With Breast Cancer
    Arnaout, Angel
    Addison, Christina
    Robertson, Susan
    Chang, Nina
    Clemons, Mark
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 28 - 28
  • [47] Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
    Sirwan M. Hadad
    Philip Coates
    Lee B. Jordan
    Ryan J. O. Dowling
    Martin C. Chang
    Susan J. Done
    Colin A. Purdie
    Pamela J. Goodwin
    Vuk Stambolic
    Stacy Moulder-Thompson
    Alastair M. Thompson
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 149 - 155
  • [48] Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate
    Lee, Oukseub
    Sullivan, Megan E.
    Xu, Yanfei
    Rogers, Chiara
    Muzzio, Miguel
    Helenowski, Irene
    Shidfar, Ali
    Zeng, Zexian
    Singhal, Hari
    Jovanovic, Borko
    Hansen, Nora
    Bethke, Kevin P.
    Gann, Peter H.
    Gradishar, William
    Kim, J. Julie
    Clare, Susan E.
    Khan, Seema A.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (01) : 25 - 34
  • [49] Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
    Hadad, Sirwan M.
    Coates, Philip
    Jordan, Lee B.
    Dowling, Ryan J. O.
    Chang, Martin C.
    Done, Susan J.
    Purdie, Colin A.
    Goodwin, Pamela J.
    Stambolic, Vuk
    Moulder-Thompson, Stacy
    Thompson, Alastair M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 149 - 155
  • [50] Results of the window-of-opportunity clinical trial D-BIOMARK: Study of biomarkers of the antitumor activity of denosumab and its role as a modulator of the immune response in early breast cancer
    Vethencourt, A.
    Trinidad, E. M.
    Duch, E. Dorca
    Petit, A.
    Soler-Monso, M. T.
    Purqueras, E.
    Brizzi, M. E.
    Garcia, M. Matas
    Perez-Chacon, G.
    Jimenez, M.
    Ciscar, M.
    Stradella, A.
    Iserte, A.
    Martinez, A. Guma
    Ortega, R.
    Gil, M. J.
    Simon, S. Pernas
    Falo, C.
    Gonzalez-Suarez, E.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S300 - S300
12345